ELTX
Elicio Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ELTX Filings
Filing Date
Form Description
Form Type
2025-12-04
Form EFFECT - Notice of Effectiveness
2025-12-04 ·
Form EFFECT - Notice of Effectiveness
2025-11-13
Form S-3 - Registration statement under Securities Act of 1933
2025-11-13 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-09-17
Form 8-K - Current report
Key Events
2025-09-17 · Key Events
Form 8-K - Current report
2025-08-12
Form 8-K - Current report
Key Events
2025-08-12 · Key Events
Form 8-K - Current report
2025-08-07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-07 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-07
Form 8-K - Current report
Key Events
2025-08-07 · Key Events
Form 8-K - Current report
2025-08-05
Form 8-K - Current report
Key Events
2025-08-05 · Key Events
Form 8-K - Current report
